Michael N. Teng

4.5k total citations
64 papers, 3.5k citations indexed

About

Michael N. Teng is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Michael N. Teng has authored 64 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 28 papers in Infectious Diseases and 16 papers in Genetics. Recurrent topics in Michael N. Teng's work include Respiratory viral infections research (42 papers), Virus-based gene therapy research (16 papers) and Viral gastroenteritis research and epidemiology (14 papers). Michael N. Teng is often cited by papers focused on Respiratory viral infections research (42 papers), Virus-based gene therapy research (16 papers) and Viral gastroenteritis research and epidemiology (14 papers). Michael N. Teng collaborates with scholars based in United States, Australia and United Kingdom. Michael N. Teng's co-authors include Peter L. Collins, Kim C. Tran, Stephen S. Whitehead, Juan Carlos de la Torre, Michael B. A. Oldstone, Marisa St. Claire, William R. Elkins, Brian R. Murphy, Biao He and Hans Schreiber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Michael N. Teng

62 papers receiving 3.4k citations

Peers

Michael N. Teng
Ultan F. Power United Kingdom
Toru Takimoto United States
Richard R. Spaete United States
Russell K. Durbin United States
Cecilia Johansson United Kingdom
Brian J. Willett United Kingdom
M. Reinacher Germany
Frédéric Baribaud United States
Michael N. Teng
Citations per year, relative to Michael N. Teng Michael N. Teng (= 1×) peers Jean‐François Eléouët

Countries citing papers authored by Michael N. Teng

Since Specialization
Citations

This map shows the geographic impact of Michael N. Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Teng more than expected).

Fields of papers citing papers by Michael N. Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Teng. The network helps show where Michael N. Teng may publish in the future.

Co-authorship network of co-authors of Michael N. Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Michael N. Teng. A scholar is included among the top collaborators of Michael N. Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael N. Teng. Michael N. Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Kim C., et al.. (2025). Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer. Molecular Therapy. 33(11). 5415–5426. 2 indexed citations
2.
Cui, Meng, et al.. (2022). Bioengineered peptibodies as blockers of ion channels. Proceedings of the National Academy of Sciences. 119(50). e2212564119–e2212564119. 5 indexed citations
3.
Jin, Weihua, Hyun Mo Yang, John A. Faulkner, et al.. (2021). Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. Frontiers in Molecular Biosciences. 8. 649575–649575. 43 indexed citations
5.
Piedra, Felipe-Andrés, Xueting Qiu, Michael N. Teng, et al.. (2020). Non-gradient and genotype-dependent patterns of RSV gene expression. PLoS ONE. 15(1). e0227558–e0227558. 12 indexed citations
6.
Reiser, Michelle, et al.. (2018). Abstract 16680: Bioengineered Peptibodies as Novel Therapeutic Potassium Channel Blockers. Circulation. 138(Suppl_1). 1 indexed citations
7.
Teng, Michael N. & Frank Wood. (2018). Bayesian Distributed Stochastic Gradient Descent. Neural Information Processing Systems. 31. 6378–6388. 5 indexed citations
8.
Whelan, Jillian N., et al.. (2016). Functional correlations of respiratory syncytial virus proteins to intrinsic disorder. Molecular BioSystems. 12(5). 1507–1526. 18 indexed citations
9.
Marketon, Jeanette I. Webster, et al.. (2013). The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation. Virology. 449. 62–69. 16 indexed citations
11.
Boyapalle, Sandhya, Terianne Wong, Michael N. Teng, et al.. (2012). Respiratory Syncytial Virus NS1 Protein Colocalizes with Mitochondrial Antiviral Signaling Protein MAVS following Infection. PLoS ONE. 7(2). e29386–e29386. 88 indexed citations
12.
Hotard, Anne L., Fyza Y. Shaikh, Su Jin Lee, et al.. (2012). A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology. 434(1). 129–136. 105 indexed citations
13.
Teng, Michael N.. (2012). The Non-Structural Proteins of RSV: Targeting Interferon Antagonists for Vaccine Development. Infectious Disorders - Drug Targets. 12(2). 129–137. 9 indexed citations
14.
McGivern, David R., et al.. (2010). Roles of the respiratory syncytial virus trailer region: Effects of mutations on genome production and stress granule formation. Virology. 406(2). 241–252. 54 indexed citations
15.
Sun, Minghao, Khalid Amine Timani, Dengyun Sun, et al.. (2007). Akt Plays a Critical Role in Replication of Nonsegmented Negative-Stranded RNA Viruses. Journal of Virology. 82(1). 105–114. 65 indexed citations
16.
Tran, Kim C., et al.. (2007). Purification and characterization of recombinant human respiratory syncytial virus nonstructural protein NS1. Protein Expression and Purification. 57(2). 261–270. 20 indexed citations
17.
Polack, Fernando P., Michael N. Teng, Peter L. Collins, et al.. (2002). A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease. The Journal of Experimental Medicine. 196(6). 859–865. 316 indexed citations
18.
Teng, Michael N., Stephen S. Whitehead, & Peter L. Collins. (2001). Contribution of the Respiratory Syncytial Virus G Glycoprotein and Its Secreted and Membrane-Bound Forms to Virus Replication in Vitro and in Vivo. Virology. 289(2). 283–296. 182 indexed citations
19.
Collins, Peter L., Alexander Bukreyev, Rachel Fearns, et al.. (1999). Rational Design of Live-Attenuated Recombinant Vaccine Virus for Human Respiratory Syncytial Virus by Reverse Genetics. Advances in virus research. 54. 423–451. 78 indexed citations
20.
Teng, Michael N., Kursad Turksen, Cindy Jacobs, Elaine Fuchs, & Hans Schreiber. (1993). Prevention of Runting and Cachexia by a Chimeric TNF Receptor-Fc Protein. Clinical Immunology and Immunopathology. 69(2). 215–222. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026